Update On The Adoption Study: Opicapone In Parkinsons Disease

Update on the ADOPTION study: opicapone in Parkinson’s disease

Opicapone for pain in PD: the OCEAN study

Joaquim Ferreria, MD, PhD: Opicapone’s Use in Levodopa-Treated Patients With Parkinson Disease

Assessing the benefits of using opicapone in early-stage PD

Opicapone: an adjuvant to levodopa in PD therapy

Design of the EPSILON trial of opicapone as an add-on to levodopa in early PD

Opicapone in PD with motor fluctuations: post-hoc analysis of BIPARK-I and II

Joaquim Ferreria, MD, PhD: The Magnitude of Effect for Opicapone in Parkinson Disease

Evaluation of cases of psychosis from opicapone safety data

A Day to Reach Further: Parkinson’s Disease Research Updates

Parkinson's Foundation

Update on the PASADENA trial of prasinezumab for Parkinson's disease

2023 Parkinson’s Update: What’s new? What’s next?

Van Andel Institute

Latest developments in symptomatic treatment of Parkinson’s disease

Morning Medical Update - Latest Research on Parkinson's

The University of Kansas Health System

Parkinson Disease Research Updates 2023 | EMPOWER U Program 2023

Cleveland Clinic

Clinical highlights in Parkinson's disease

Challenges faced in the clinical assessment of non-motor features in Parkinson’s disease

Morning Routine of a Mom Living with Parkinson's Disease

Parkinson's Foundation

Does Young Onset Parkinson's Disease Mean My Life is Over? #Shorts

LivedHealth Parkinson's

A Novel Treatment and Other Parkinson's Updates From AAN 2022